相关实验视频
Updated: Jul 20, 2025

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
建立不同年龄阶段老年人CAP的风险模型:单中心回顾性观察性研究
Chunxin Lv1, Teng Pan2,3, Wen Shi4
1Oncology Department, Shanghai Punan Hospital of Pudong New District, No 279, Linyi Road, Pudong, Shanghai, China.
使用Albumin,BUN,NLR和Pulse的新ABNP模型有效地预测了社区获得的老年肺炎患者的死亡率. 该模型在不同年龄组的现有分数中表现出色,改善了老年人风险分层.
科学领域:
- 老年医学 老年医学
- 传染性疾病 传染性疾病
- 临床流行病学 临床流行病学
背景情况:
- 社区获得性肺炎 (CAP) 显著影响老年人的死亡率和发病率.
- 目前的评分系统无法预测65岁以上患者的死亡率.
- 现有的模型没有有效地预测CAP在不同老年阶段的发病率和死亡率.
研究的目的:
- 调查年龄对制定一个评估模型的CAP死亡率的影响.
- 确定预后因素和新的生物标志物,用于预测老年CAP患者的死亡率.
- 建立一个准确的,特定于年龄的预测模型,用于 CAP 相关的老年人死亡率.
主要方法:
- 对老年CAP患者的回顾性分析.
- 单变数和多变数逻辑回归用于年龄子组内的预后因素识别.
- 使用接收器运行特征曲线和曲线下面面积 (AUC) 分析开发和验证白蛋白,BUN,NLR和脉冲 (ABNP) 模型.
主要成果:
- 四个因素Albumin,BUN,NLR和Pulse在所有年龄组中显示出独立的预后意义.
- 该ABNP模型显示高预测准确度,AUC值为0.888,0.912和0.872,分别为66-75,76-85岁和85岁以上的年龄组.
- 在预测不同老年年龄层的死亡率方面,ABNP模型的表现优于PSI,CURB-65和qSOFA.
结论:
- 该ABNP模型提供了一个强大而准确的工具,用于预测老年CAP患者的住院死亡率.
- 特定年龄的风险分层对于老年人中CAP管理至关重要.
- 与老年CAP患者的现有临床评分相比,ABNP模型提供了优越的预测性能.
更多相关视频
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
相关概念视频
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History